Report Detail
Global Live Attenuated Vaccines for Poultry Market Growth 2022-2028
- RnM4470309 |
- 25 July, 2022 |
- Global |
- 100 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Live Attenuated Vaccines for Poultry will have significant change from previous year. According to our (LP Information) latest study, the global Live Attenuated Vaccines for Poultry market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Live Attenuated Vaccines for Poultry market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Live Attenuated Vaccines for Poultry market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Live Attenuated Vaccines for Poultry market, reaching US$ million by the year 2028. As for the Europe Live Attenuated Vaccines for Poultry landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Live Attenuated Vaccines for Poultry players cover MERCK, Boehringer Ingelheim, ELANCO, and QYH BIOTECH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Vaccines for Poultry market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Spray
Eye Drop
Oral
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Chicken
Cattle
Horse
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
HIPRA
Kemin Biologics
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Live Attenuated Vaccines for Poultry Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Live Attenuated Vaccines for Poultry by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Live Attenuated Vaccines for Poultry by Country/Region, 2017, 2022 & 2028
- 2.2 Live Attenuated Vaccines for Poultry Segment by Type
- 2.2.1 Spray
- 2.2.2 Eye Drop
- 2.2.3 Oral
- 2.2.4 Others
- 2.3 Live Attenuated Vaccines for Poultry Sales by Type
- 2.3.1 Global Live Attenuated Vaccines for Poultry Sales Market Share by Type (2017-2022)
- 2.3.2 Global Live Attenuated Vaccines for Poultry Revenue and Market Share by Type (2017-2022)
- 2.3.3 Global Live Attenuated Vaccines for Poultry Sale Price by Type (2017-2022)
- 2.4 Live Attenuated Vaccines for Poultry Segment by Application
- 2.4.1 Chicken
- 2.4.2 Cattle
- 2.4.3 Horse
- 2.4.4 Others
- 2.5 Live Attenuated Vaccines for Poultry Sales by Application
- 2.5.1 Global Live Attenuated Vaccines for Poultry Sale Market Share by Application (2017-2022)
- 2.5.2 Global Live Attenuated Vaccines for Poultry Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Live Attenuated Vaccines for Poultry Sale Price by Application (2017-2022)
3 Global Live Attenuated Vaccines for Poultry by Company
- 3.1 Global Live Attenuated Vaccines for Poultry Breakdown Data by Company
- 3.1.1 Global Live Attenuated Vaccines for Poultry Annual Sales by Company (2020-2022)
- 3.1.2 Global Live Attenuated Vaccines for Poultry Sales Market Share by Company (2020-2022)
- 3.2 Global Live Attenuated Vaccines for Poultry Annual Revenue by Company (2020-2022)
- 3.2.1 Global Live Attenuated Vaccines for Poultry Revenue by Company (2020-2022)
- 3.2.2 Global Live Attenuated Vaccines for Poultry Revenue Market Share by Company (2020-2022)
- 3.3 Global Live Attenuated Vaccines for Poultry Sale Price by Company
- 3.4 Key Manufacturers Live Attenuated Vaccines for Poultry Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Live Attenuated Vaccines for Poultry Product Location Distribution
- 3.4.2 Players Live Attenuated Vaccines for Poultry Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Live Attenuated Vaccines for Poultry by Geographic Region
- 4.1 World Historic Live Attenuated Vaccines for Poultry Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Live Attenuated Vaccines for Poultry Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Live Attenuated Vaccines for Poultry Annual Revenue by Geographic Region
- 4.2 World Historic Live Attenuated Vaccines for Poultry Market Size by Country/Region (2017-2022)
- 4.2.1 Global Live Attenuated Vaccines for Poultry Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Live Attenuated Vaccines for Poultry Annual Revenue by Country/Region
- 4.3 Americas Live Attenuated Vaccines for Poultry Sales Growth
- 4.4 APAC Live Attenuated Vaccines for Poultry Sales Growth
- 4.5 Europe Live Attenuated Vaccines for Poultry Sales Growth
- 4.6 Middle East & Africa Live Attenuated Vaccines for Poultry Sales Growth
5 Americas
- 5.1 Americas Live Attenuated Vaccines for Poultry Sales by Country
- 5.1.1 Americas Live Attenuated Vaccines for Poultry Sales by Country (2017-2022)
- 5.1.2 Americas Live Attenuated Vaccines for Poultry Revenue by Country (2017-2022)
- 5.2 Americas Live Attenuated Vaccines for Poultry Sales by Type
- 5.3 Americas Live Attenuated Vaccines for Poultry Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Live Attenuated Vaccines for Poultry Sales by Region
- 6.1.1 APAC Live Attenuated Vaccines for Poultry Sales by Region (2017-2022)
- 6.1.2 APAC Live Attenuated Vaccines for Poultry Revenue by Region (2017-2022)
- 6.2 APAC Live Attenuated Vaccines for Poultry Sales by Type
- 6.3 APAC Live Attenuated Vaccines for Poultry Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Live Attenuated Vaccines for Poultry by Country
- 7.1.1 Europe Live Attenuated Vaccines for Poultry Sales by Country (2017-2022)
- 7.1.2 Europe Live Attenuated Vaccines for Poultry Revenue by Country (2017-2022)
- 7.2 Europe Live Attenuated Vaccines for Poultry Sales by Type
- 7.3 Europe Live Attenuated Vaccines for Poultry Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Live Attenuated Vaccines for Poultry by Country
- 8.1.1 Middle East & Africa Live Attenuated Vaccines for Poultry Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Live Attenuated Vaccines for Poultry Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Live Attenuated Vaccines for Poultry Sales by Type
- 8.3 Middle East & Africa Live Attenuated Vaccines for Poultry Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Live Attenuated Vaccines for Poultry
- 10.3 Manufacturing Process Analysis of Live Attenuated Vaccines for Poultry
- 10.4 Industry Chain Structure of Live Attenuated Vaccines for Poultry
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Live Attenuated Vaccines for Poultry Distributors
- 11.3 Live Attenuated Vaccines for Poultry Customer
12 World Forecast Review for Live Attenuated Vaccines for Poultry by Geographic Region
- 12.1 Global Live Attenuated Vaccines for Poultry Market Size Forecast by Region
- 12.1.1 Global Live Attenuated Vaccines for Poultry Forecast by Region (2023-2028)
- 12.1.2 Global Live Attenuated Vaccines for Poultry Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Live Attenuated Vaccines for Poultry Forecast by Type
- 12.7 Global Live Attenuated Vaccines for Poultry Forecast by Application
13 Key Players Analysis
- 13.1 MERCK
- 13.1.1 MERCK Company Information
- 13.1.2 MERCK Live Attenuated Vaccines for Poultry Product Offered
- 13.1.3 MERCK Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 MERCK Main Business Overview
- 13.1.5 MERCK Latest Developments
- 13.2 Boehringer Ingelheim
- 13.2.1 Boehringer Ingelheim Company Information
- 13.2.2 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Product Offered
- 13.2.3 Boehringer Ingelheim Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Boehringer Ingelheim Main Business Overview
- 13.2.5 Boehringer Ingelheim Latest Developments
- 13.3 ELANCO
- 13.3.1 ELANCO Company Information
- 13.3.2 ELANCO Live Attenuated Vaccines for Poultry Product Offered
- 13.3.3 ELANCO Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 ELANCO Main Business Overview
- 13.3.5 ELANCO Latest Developments
- 13.4 QYH BIOTECH
- 13.4.1 QYH BIOTECH Company Information
- 13.4.2 QYH BIOTECH Live Attenuated Vaccines for Poultry Product Offered
- 13.4.3 QYH BIOTECH Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 QYH BIOTECH Main Business Overview
- 13.4.5 QYH BIOTECH Latest Developments
- 13.5 CEVA
- 13.5.1 CEVA Company Information
- 13.5.2 CEVA Live Attenuated Vaccines for Poultry Product Offered
- 13.5.3 CEVA Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 CEVA Main Business Overview
- 13.5.5 CEVA Latest Developments
- 13.6 HIPRA
- 13.6.1 HIPRA Company Information
- 13.6.2 HIPRA Live Attenuated Vaccines for Poultry Product Offered
- 13.6.3 HIPRA Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 HIPRA Main Business Overview
- 13.6.5 HIPRA Latest Developments
- 13.7 Kemin Biologics
- 13.7.1 Kemin Biologics Company Information
- 13.7.2 Kemin Biologics Live Attenuated Vaccines for Poultry Product Offered
- 13.7.3 Kemin Biologics Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Kemin Biologics Main Business Overview
- 13.7.5 Kemin Biologics Latest Developments
- 13.8 ZOETIS
- 13.8.1 ZOETIS Company Information
- 13.8.2 ZOETIS Live Attenuated Vaccines for Poultry Product Offered
- 13.8.3 ZOETIS Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 ZOETIS Main Business Overview
- 13.8.5 ZOETIS Latest Developments
- 13.9 Vaxxinova
- 13.9.1 Vaxxinova Company Information
- 13.9.2 Vaxxinova Live Attenuated Vaccines for Poultry Product Offered
- 13.9.3 Vaxxinova Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Vaxxinova Main Business Overview
- 13.9.5 Vaxxinova Latest Developments
- 13.10 PULIKE
- 13.10.1 PULIKE Company Information
- 13.10.2 PULIKE Live Attenuated Vaccines for Poultry Product Offered
- 13.10.3 PULIKE Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 PULIKE Main Business Overview
- 13.10.5 PULIKE Latest Developments
- 13.11 PHIBRO ANIMAL HEALTH CORPORATION
- 13.11.1 PHIBRO ANIMAL HEALTH CORPORATION Company Information
- 13.11.2 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Product Offered
- 13.11.3 PHIBRO ANIMAL HEALTH CORPORATION Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 PHIBRO ANIMAL HEALTH CORPORATION Main Business Overview
- 13.11.5 PHIBRO ANIMAL HEALTH CORPORATION Latest Developments
- 13.12 JINYU BIOTECHNOLOGY
- 13.12.1 JINYU BIOTECHNOLOGY Company Information
- 13.12.2 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Product Offered
- 13.12.3 JINYU BIOTECHNOLOGY Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.12.4 JINYU BIOTECHNOLOGY Main Business Overview
- 13.12.5 JINYU BIOTECHNOLOGY Latest Developments
- 13.13 HARBIN PHARMACEUTICAL GROUP
- 13.13.1 HARBIN PHARMACEUTICAL GROUP Company Information
- 13.13.2 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Product Offered
- 13.13.3 HARBIN PHARMACEUTICAL GROUP Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.13.4 HARBIN PHARMACEUTICAL GROUP Main Business Overview
- 13.13.5 HARBIN PHARMACEUTICAL GROUP Latest Developments
- 13.14 MEVAC
- 13.14.1 MEVAC Company Information
- 13.14.2 MEVAC Live Attenuated Vaccines for Poultry Product Offered
- 13.14.3 MEVAC Live Attenuated Vaccines for Poultry Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.14.4 MEVAC Main Business Overview
- 13.14.5 MEVAC Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Live Attenuated Vaccines for Poultry. Industry analysis & Market Report on Live Attenuated Vaccines for Poultry is a syndicated market report, published as Global Live Attenuated Vaccines for Poultry Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Live Attenuated Vaccines for Poultry market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
